Genetics, diet quality independently linked to T2DM risk
Apr 28, 2022
Low diet quality versus high diet quality was linked to about a 30% increase in risk for type 2 diabetes regardless of genetic risk.
Gestational diabetes mellitus may up risk for range of later cardiovascular conditions
Feb 10, 2022
Traditional risk factors such as subsequent diabetes, hypertension and dyslipidemia only partially contribute to higher risk.
Rehospitalization increased with delayed home healthcare in diabetes
Sep 09, 2021
Racial/ethnic-minority patients are less likely to receive services within 14 days after discharge to home healthcare.
House passes bill to limit insulin costs to $35 a month
Apr 01, 2022
The bill now has to pass the Senate with at least 10 Republican votes.
Achieving treatment goals in T2DM can up life expectancy
Apr 19, 2022
Life expectancy gains were seen with reducing HbA1c, SBP, LDL-C and BMI among individuals with type 2 diabetes.
Consensus statement defines remission of type 2 diabetes
Sep 07, 2021
Remission is defined as HbA1c <6.5% for at least three months after cessation of glucose-lowering pharmacotherapy.
More steps per day may cut risk for incident diabetes in seniors
Jan 27, 2022
“It’s not enough for somebody to go on a walk once a week,” the lead author said in a statement. “Our study indicates that regular stepping is indicative of lower diabetes risk...
Lipid profiling can predict future risk for type 2 diabetes, CVD
Mar 11, 2022
In the highest-risk groups for T2D and CVD, significantly altered lipidome compositions affected 167 and 157 lipid species, respectively.
Meta-analysis shows prevalence of statin intolerance Is low
Feb 16, 2022
The prevalence of statin intolerance was 9.1% overall; significant associations were seen for age, female gender, Asian and Black race, obesity and diabetes mellitus.
FDA approves first biosimilar insulin product
Jul 29, 2021
Semglee (insulin glargine-yfgn) is biosimilar to and interchangeable with Lantus (insulin glargine) and provides a cost-effective option.